-+ 0.00%
-+ 0.00%
-+ 0.00%

SEAPORT THERAPEUTICS PRESENTS ADDITIONAL PHARMACOKINETIC DATA FROM PHASE 1 CLINICAL TRIAL OF GLYPHAGO™ AT THE 39TH EUROPEAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY (ECNP) CONGRESS

Reuters·10/09/2026 11:02:12